Training program to improve research on COVID-19, heart disease, and diabetes in people with HIV in Mozambique
Official title: Pitt-Mozambique Training Program(Pitt-MozHRTP) in COVID-19, Cardiovascular Disease, and Diabetes in People with HIV
Funded at University of Pittsburgh at Pittsburgh · NIH-11011354 · Data updated 2026-11-12
This program is all about helping local researchers in Mozambique learn more about COVID-19, heart disease, and diabetes in people living with HIV, so they can better tackle these important health issues in their communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | May 2, 2022 |
| Project end | January 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $58,014 |
| NIH project number | 5D43TW011827-04 |
| Project ID | NIH-11011354 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living with HIV in Mozambique who are affected by COVID-19, cardiovascular disease, or diabetes.
✕Less likely to help
Patients who do not have HIV or are not affected by the targeted conditions may not benefit from this research.
What this research studies
This program aims to enhance research capabilities in Mozambique by training local researchers in the areas of COVID-19, cardiovascular disease, and diabetes among individuals living with HIV. It involves collaboration between the University of Pittsburgh and local health research centers in Mozambique, focusing on building expertise in epidemiology, biostatistics, and laboratory sciences. Participants will have access to various degree programs and post-doctoral fellowships, along with workshops designed to strengthen their research skills and knowledge. The initiative seeks to address critical health challenges faced by the population in Mozambique.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for people living with HIV by enhancing understanding and management of COVID-19, cardiovascular disease, and diabetes.
How similar studies have gone: Previous research initiatives in similar contexts have shown promise in building local research capacity and improving health outcomes, indicating a potential for success with this approach.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Harrison, Lee H — University of Pittsburgh at Pittsburgh
- Study coordinator: Harrison, Lee H
Related research
Other NIH-funded projects on the same topics.
-
TB infection and heart health: how latent TB may raise diabetes and heart disease risk
This project looks at whether having latent tuberculosis infection raises the chances of developing diabetes and cardiovascular disease, and what epigenetic clues might explain this link.
-
Understanding how APOC3 affects heart disease in diabetes
This grant studies how a protein called APOC3 influences heart disease risk in people with diabetes, aiming to find ways to reduce that risk.
-
Triglycerides, Diabetes, and Heart Disease in Diabetes Patients
A large, multi-year study from the University of Washington looks at how triglyceride-rich particles affect heart disease risk in adults with type 2 diabetes.
-
Understanding Hydrogen Sulfide's Role in Diabetes and Heart Health
This project looks at how a natural gas in our bodies, called hydrogen sulfide, might be connected to developing type 2 diabetes and heart problems.
-
Understanding Type 2 Diabetes, APOC3, and Heart Disease
This work explores how a protein called APOC3 contributes to heart disease in people with type 2 diabetes.
-
Understanding Fats, Diabetes, and Heart Disease
This research aims to understand how certain fats, called triglycerides, contribute to heart disease in people with type 2 diabetes.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.